Survodutide 10mg - Dragon Pharma
Optimize your research with Survodutide, a high-quality formulation by Dragon Pharma. Designed for precision, this compound is a key subject in studies regarding metabolic health and liver-related conditions.
Specifications
| Active Substance | Survodutide |
| Form | 1 vial x 10 mg |
| Manufacturer | Dragon 10mg |
Description/How it works
Survodutide (BI-456906) is a research-grade compound currently under investigation for its efficacy in treating renal failure, non-alcoholic steatohepatitis (NASH), liver fibrosis, type 2 diabetes, and obesity. The mechanism of action involves the activation of the glucagon-like peptide 1 receptor (GLP-1R). This receptor-mediated process is crucial for its potential applications in metabolic and liver disease research, making it a vital tool for scientific study.
Shipping & Delivery
Please note that temporary shipping restrictions apply to Hawaii and Alaska. Additionally, military addresses, including APO and FPO, are currently not supported.